Immunohistochemical analysis of PDX tumors confirmed that BRD4 was degraded by 84-EBET on both cancer and stromal cells in the tumors, suggesting that EBET diffused from the cancer cells had a bystander effect on CEACAM6-negative stromal cells (Fig. 5a, b). Here, BRD4 is linked to cancer.